Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9696)
All Articles published online
|
Publishing Process of This Article
|
Jun 14, 2017 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Koller T, Galambosova M, Filakovska S, Kubincova M, Hlavaty T, Toth J, Krajcovicova A, Payer J. Drug-induced liver injury in inflammatory bowel disease: 1-year prospective observational study. World J Gastroenterol 2017; 23(22): 4102-4111 [PMID: 28652663 DOI: 10.3748/wjg.v23.i22.4102] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i22/4102.htm |
| Number | Citing Articles |
| 1 |
Rocco Spagnuolo, Tiziana Montalcini, Daniele De Bonis, Yvelise Ferro, Cristina Cosco, Elisa Mazza, Stefano Romeo, Patrizia Doldo, Arturo Pujia. Weight Gain and Liver Steatosis in Patients with Inflammatory Bowel Diseases. Nutrients 2019; 11(2): 303 doi: 10.3390/nu11020303
|
| 2 |
Vlad Alexandru Ionescu, Gina Gheorghe, Valentin Nicolae Varlas, Ana Maria Alexandra Stanescu, Camelia Cristina Diaconu. Hepatobiliary Impairments in Patients with Inflammatory Bowel Diseases: The Current Approach. Gastroenterology Insights 2022; 14(1): 13 doi: 10.3390/gastroent14010002
|
| 3 |
M. Nedim Ince, David E. Elliott. Effective Use of the Laboratory in the Management of Patients with Inflammatory Bowel Diseases. Gastroenterology Clinics of North America 2019; 48(2): 237 doi: 10.1016/j.gtc.2019.02.006
|
| 4 |
Maya Frank Wolf, Ronen Sloma, Luiza Akria, Eli Rimon, Yifat Wiener, Michal Carmiel Haggai, Lior Lowenstein. Azathioprine and 6-mercaptopurine-induced intrahepatic cholestasis of pregnancy: Case report and review of the literature. Taiwanese Journal of Obstetrics and Gynecology 2023; 62(5): 761 doi: 10.1016/j.tjog.2023.07.023
|
| 5 |
Gadour Eyad, Hassan Zeinab. Systematic review and meta-analysis of drug induced liver injury secondary to biologic medications in inflammatory bowel disease. Annals of Clinical Gastroenterology and Hepatology 2021; 5(1): 005 doi: 10.29328/journal.acgh.1001025
|
| 6 |
Beverley Kok, Erica L. W. Lester, William M. Lee, A. James Hanje, R. Todd Stravitz, Safwat Girgis, Vaishali Patel, Joshua R. Peck, Christopher Esber, Constantine J. Karvellas. Acute Liver Failure from Tumor Necrosis Factor-α Antagonists: Report of Four Cases and Literature Review. Digestive Diseases and Sciences 2018; 63(6): 1654 doi: 10.1007/s10620-018-5023-6
|
| 7 |
Parth Shah, Vinay Sundaram, Einar Björnsson. Biologic and Checkpoint Inhibitor‐Induced Liver Injury: A Systematic Literature Review. Hepatology Communications 2020; 4(2): 172 doi: 10.1002/hep4.1465
|
| 8 |
Fernando Bessone, Einar S. Björnsson. Drug-Induced Liver Injury due to Biologics and Immune Check Point Inhibitors. Medical Clinics of North America 2023; 107(3): 623 doi: 10.1016/j.mcna.2022.12.008
|
| 9 |
Shaya Noorian, Yejoo Jeon, Minh T Nguyen, Jenny Sauk, Berkeley N Limketkai. The Impact of NAFLD on Hospitalization Outcomes in Patients With Inflammatory Bowel Diseases: Nationwide Analysis. Inflammatory Bowel Diseases 2022; 28(6): 878 doi: 10.1093/ibd/izab199
|
| 10 |
Jeroen P.A. Houwen, Antoine C.G. Egberts, Anthonius de Boer, Erik M. van Maarseveen, Roderick H.J. Houwen, Arief Lalmohamed. Influence of allopurinol on thiopurine associated toxicity: A retrospective population‐based cohort study. British Journal of Clinical Pharmacology 2021; 87(5): 2333 doi: 10.1111/bcp.14625
|
| 11 |
Matei Alexandru Cozma, Matei Mandea, Camelia Cristina Diaconu. Antidotes to Toxins and Drugs. 2024; : 195 doi: 10.1016/B978-0-12-824472-2.00008-7
|
| 12 |
Saber Jedidi, Kais Rtibi, Houcine Selmi, Foued Aloui, Nourhène Dhawefi, Hichem Sebai. Hepato-Nephroprotective Actions of Salvia officinalis Decoction Extract Against Extraintestinal Alterations Induced with Acetic Acid-Colitis Model in Rats. Journal of Medicinal Food 2023; 26(6): 390 doi: 10.1089/jmf.2023.0006
|
| 13 |
|
| 14 |
Zi-Yuan Zou, Bo Shen, Jian-Gao Fan. Systematic Review With Meta-analysis: Epidemiology of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2019; 25(11): 1764 doi: 10.1093/ibd/izz043
|
| 15 |
G. V. Volynets, A. I. Khavkin. Inflammatory bowel disease and drug-induced liver damage. Experimental and Clinical Gastroenterology 2021; (10): 138 doi: 10.31146/1682-8658-ecg-194-10-138-146
|
| 16 |
Michele S. Barnhill, Joshua M. Steinberg, Joseph J. Jennings, James H. Lewis. Hepatotoxicty of Agents Used in the Management of Inflammatory Bowel Disease: a 2020 Update. Current Gastroenterology Reports 2020; 22(9) doi: 10.1007/s11894-020-00781-3
|
| 17 |
Joanna Leaviss, Christopher Carroll, Munira Essat, Danielle van der Windt, Matthew J Grainge, Tim Card, Richard Riley, Abhishek Abhishek. Prognostic factors for liver, blood and kidney adverse events from glucocorticoid sparing immune-suppressing drugs in immune-mediated inflammatory diseases: a prognostic systematic review. RMD Open 2024; 10(1): e003588 doi: 10.1136/rmdopen-2023-003588
|
| 18 |
Pilar Navarro, Lucía Gutiérrez-Ramírez, Antonio Tejera-Muñoz, Ángel Arias, Alfredo J. Lucendo. Systematic Review and Meta-Analysis: Prevalence of Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Patients with Inflammatory Bowel Disease. Nutrients 2023; 15(21): 4507 doi: 10.3390/nu15214507
|
| 19 |
Giuseppe Losurdo, Irene Vita Brescia, Chiara Lillo, Martino Mezzapesa, Michele Barone, Mariabeatrice Principi, Enzo Ierardi, Alfredo Di Leo, Maria Rendina. Liver involvement in inflammatory bowel disease: What should the clinician know?. World Journal of Hepatology 2021; 13(11): 1534-1551 doi: 10.4254/wjh.v13.i11.1534
|
| 20 |
Qiuping Guo, Jianmin Guo, Guiying Chen, Zhong Han, Baiquan Xiao, Ruomin Jin, Chun Liang, Wei Yang. Biomarkers associated with binaprofen‑induced liver injury. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.9549
|
| 21 |
Ya. A. Krasner, Yu. A. Kulygina, E. Yu. Valuyskikh, M. F. Osipenko. Prevalence and characteristics of non-alcoholic steatohepatitis in patients with inflammatory bowel disease in the Novosibirsk region: a cross-sectional, one center study in 245 patients. Almanac of Clinical Medicine 2018; 46(5): 464 doi: 10.18786/2072-0505-2018-46-5-464-473
|
| 22 |
Hélène Céruti, Gilles Kayem, Lucie Guilbaud, Chloé Dussaux, Anne Gervais, Aurélie Beaufrère, Benoit Coffin, Laurent Mandelbrot, Emeline Maisonneuve. Intrahepatic cholestasis of pregnancy associated with azathioprine: A case series. Journal of Gynecology Obstetrics and Human Reproduction 2021; 50(4): 102083 doi: 10.1016/j.jogoh.2021.102083
|
| 23 |
Paulina Núñez F, Fabiola Castro, Gabriel Mezzano, Rodrigo Quera, Diego Diaz, Lorena Castro. Hepatobiliary manifestations in inflammatory bowel disease: A practical approach. World Journal of Hepatology 2022; 14(2): 319-337 doi: 10.4254/wjh.v14.i2.319
|
| 24 |
Tomoo Nakagawa, Taku Kobayashi, Kiyohiro Nishikawa, Fumika Yamada, Satoshi Asai, Yukinori Sameshima, Yasuo Suzuki, Mamoru Watanabe, Toshifumi Hibi. Infliximab biosimilar CT-P13 is interchangeable with its originator for patients with inflammatory bowel disease in real world practice. Intestinal Research 2019; 17(4): 504 doi: 10.5217/ir.2019.00030
|
| 25 |
K. BRAZDILOVA, T. KOLLER, Z. KILLINGER, J. PAYER. Prevalence and Risk Factors for Drug-Induced Liver Injury Among Patients With Rheumatic Diseases Treated With Biological Therapy: A Single-Center Experience. Physiological Research 2019; : S157 doi: 10.33549/physiolres.934299
|
| 26 |
Ali ATAY, Yasemin ÖZDERİN ÖZİN, Dilara TURAN GÖKÇE, Müge BÜYÜKAKSOY, Gamze DEMİREL, Meral AKDOĞAN KAYHAN, Zeki Mesut Yalın KILIÇ, Emin ALTIPARMAK. İnflamatuvar bağırsak hastalığı olan hastalarda immünmodülatör tedaviler güvenli mi? 23 yıllık tek merkez deneyimi. Akademik Gastroenteroloji Dergisi 2023; 22(3): 142 doi: 10.17941/agd.1405423
|
| 27 |
Paulina Núñez F, Rodrigo Quera, Constanza Bay, Fabiola Castro, Gabriel Mezzano. Drug-Induced Liver Injury Used in the Treatment of Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2022; 16(7): 1168 doi: 10.1093/ecco-jcc/jjac013
|
| 28 |
Adil S. MIR, Dario SORRENTINO. Non-cirrhotic portal hypertension in inflammatory bowel disease. Minerva Gastroenterology 2023; 69(2) doi: 10.23736/S2724-5985.20.02684-7
|
| 29 |
Farzaneh Maleki, Elias Clark, Christopher Banfield, Wonkyung Byon, Timothy Nicholas. Population pharmacokinetic modeling of oral brepocitinib in healthy volunteers and patients with immuno‐inflammatory diseases. CPT: Pharmacometrics & Systems Pharmacology 2024; 13(4): 551 doi: 10.1002/psp4.13100
|